Dr Pedro Guillén
Pedro Guillén, founder and president of Clínica Cemtro, president of the Dr Pedro Guillén Foundation, extraordinary professor and honorary dean of the Catholic University of Murcia, and honorary member of the Royal European Academy of Doctors (RAED), has received one of the 2026 Admirables Awards granted by the specialist publication Diario Médico in recognition of his scientific and professional career. “Pedro Guillén stands out as one of the most influential figures in traumatology, orthopaedic surgery and sports medicine at international level,” the jury stated. The academic received the distinction at a gala held on 25 May at the Royal Tapestry Factory in Madrid. The event brought together some of the most prominent figures in Spanish healthcare and formed part of the celebrations marking the 34th anniversary of this leading publication in the health sector. Eleven other outstanding professionals in medicine, pharmacy and nursing were honoured alongside Guillén.
The event was attended by institutional representatives and healthcare professionals, including Javier Padilla, Secretary of State for Health; Fátima Matute, Minister of Health of the Community of Madrid; and María Martín Díez de Baldeón, Minister of Health and Social Policies of La Rioja. During the ceremony, Diario Médico underlined the importance of giving visibility to healthcare professionals and to the sector’s commitment to innovation, research and patient care. Throughout his career, Guillén has driven pioneering advances in arthroscopic surgery and regenerative medicine. His work has contributed to the development of new strategies for recovery from injury and the treatment of joint deterioration. From Clínica Cemtro he continues to lead projects involving biomedical research, cell therapy and innovation applied to sports and trauma medicine.
In Diario Médico itself last April, Guillén announced that he is considering introducing partial cellular reprogramming in Spain to treat knee osteoarthritis. This innovative technique, developed and already approved by the Japanese health system, uses human cells to regenerate damaged tissue and thereby avoid aggressive treatments such as joint replacement. In the longer term, Guillén envisages the use of such therapies for cardiovascular, liver and neurological diseases that likewise involve cellular degeneration or necrosis.
The pioneer who introduced arthroscopy in Spain, Guillén is also a member of the National Academy of Surgery of Spain, the Royal National Academy of Pharmacy, the European College of Sports Traumatology and the Spanish Committee of Sports Medicine, and an honorary member of the Arthroscopy Association of North America. He has received some of Spain’s highest civil distinctions, including the Medal for Merit in Labour, the Grand Cross of the Order of the Second of May and the Medal of Honour for the Promotion of Invention, among other major awards. In teaching and research, he promotes the Pedro Guillén Chair in Regenerative Medicine.
